Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Immune Pharmaceuticals Inc. (IMNPQ) had Debt to Capital Ratio of 0.10 for the most recently reported fiscal year, ending 2017-12-31.
| Income Statement Financials | |
-- |
|
$-24.75M |
|
-- |
|
-- |
|
$12.12M |
|
$-12.12M |
|
$-7.74M |
|
$-19.86M |
|
$-19.71M |
|
$-17.89M |
|
$-17.89M |
|
$-17.89M |
|
$-17.73M |
|
$-12.12M |
|
$-8.82M |
|
11.76M |
|
11.76M |
|
$-2.11 |
|
$-2.11 |
|
| Balance Sheet Financials | |
$7.03M |
|
-- |
|
$21.58M |
|
$28.61M |
|
$9.25M |
|
$1.46M |
|
$5.60M |
|
$14.85M |
|
$13.76M |
|
$7.28M |
|
$13.76M |
|
21.00M |
|
| Cash Flow Statement Financials | |
$-11.56M |
|
$0.03M |
|
$18.03M |
|
$0.27M |
|
$6.78M |
|
$6.50M |
|
$0.75M |
|
-- |
|
$-0.02M |
|
| Fundamental Metrics & Ratios | |
0.76 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.10 |
0.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-130.03% |
|
-245.69% |
|
-62.53% |
|
-117.57% |
|
$0.66 |
|
$-0.99 |
|
$-0.98 |
|